Allergan Physician Production Information. Botox cosmetic (botulinum toxin type A). Published April 2008.
Baran R, Maibach H.
Textbook of Cosmetic Dermatology. 3rd ed. New York, NY: Taylor and Francis; 2004.
Conn HF, Rakel R.
Conn’s Current Therapy.
54th ed. Philadelphia, PA: WB Saunders Company; 2002.
Clinical Dermatology. 4th ed. St. Louis, MO: Mosby; 2004.
Ondo WG, Gollomp S, Galvez-Jimenez N. A pilot study of botulinum toxin A for headache in cervical dystonia.
Ward A, Roberts G, Warner J, et al. Cost-effectiveness of botulinum toxin type A in the treatment of post-stroke spasticity.
J Rehabil Med. 2005;37(4):252-257.
11/4/2009 DynaMed Systematic Literature Surveillance
DynaMed's Systematic Literature Surveillance: FDA gives update on botulinum toxin safety warnings. US Food and Drug Administration website. Available at:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm175013.htm. Updated August 3, 2009. Accessed November 4, 2009.
3/19/2010 DynaMed Systematic Literature Surveillance
DynaMed's Systematic Literature Surveillance: FDA approves Botox to treat spasticity in flexor muscles of the elbow, wrist and fingers. US Food and Drug Administration website. Available at:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm203776.htm. Updated March 9, 2010. Accessed March 19, 2010.
Please be aware that this information is provided to supplement the care
provided by your physician. It is neither intended nor implied to be a
substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER
IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the
advice of your physician or other qualified health provider prior to
starting any new treatment or with any questions you may have regarding a
Copyright © 2007
EBSCO Publishing All rights reserved.